2022 Training Calendar

TB Intensive Workshop
Date: July 12 - 15
Location:
Rutgers New Jersey Medical School
185 South Orange Avenue
Medical Science Building, Room B619
Newark, NJ 07103

COURSE DESCRIPTION & OVERALL GOAL
This workshop provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special populations. Topics include transmission and pathogenesis, diagnosis and treatment, drug resistance, TB-HIV co-infection, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.

AGENDA

WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospitals
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Settings
  • College or University Health Services
WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
  • Apply the latest advances for assessing risk, testing and treating TB infection to prevent development of disease.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • Integrate current recommendations for the prevention and management of tuberculosis in children and adolescents.
  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.
  • Develop strategies for the care of TB patients with co-morbidities to ensure prompt diagnosis, integrated treatment, and effective management.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 3 months of the course.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

APPLICATION INFORMATION & FEE
This course requires an application process. Please click below to apply:
https://www.surveymonkey.com/r/TBIWSIP2022

Please note that the fee for this course is $150 a separate link will be shared after your admission in the course. Payment must be received prior to the course. Breakfast and lunch will be provided.

Notification of acceptance and additional course information will be sent via email.

Check or money order payments should be made payable to Rutgers Global Tuberculosis Institute and mailed to:

Global Tuberculosis Institute
225 Warren Street, 1st Floor, East Wing
Newark, NJ 07103
Attention: Shwata Suresh Kumar

CANCELLATION AND REFUND INFORMATION
Please note that refunds will only be issued if applicants notify our office of a cancellation by June 28. We will not be able to provide any refunds if applicants cancel after the deadline.

We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Shwata Suresh Kumar at
ss2980@rutgers.edu

For more information, please contact Shwata Suresh Kumar at ss2980@rutgers.edu

FACULTY

E. Jane Carter, MD
Professor of Medicine
Warren Alpert Medical School, Brown University

Henry Fraimow, MD
Assistant Professor of Medicine
Cooper Medical School of Rowan University

Barry Kreiswirth, PhD
Adjunct Faculty Member
New York University

Jyoti Mathad, MD
Assistant Professor of Medicine
Weill Cornell Medical College, Cornell University

George McSherry, MD
Chief, Pediatric Infectious Disease Division
Penn State Children's Hospital

Rashun Miles
Patient Advocate
We Are TB

Darlene Morse, MSN, RN, MEd, CIC
Nurse Consultant
Global Tuberculosis Institut
e

Navaneeth Narayanan, PharmD, MPH
Clinical Assistant Professor
Rutgers University, Ernest Mario School of Pharmacy

Maggy Ngombi
Patient Advocate
We Are TB

Diana Nilsen, MD
Director of Medical Affairs, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Kate O'Brien
Patient Advocate
We Are TB

Amee Patrawalla, MD, MPH
Medical Director
Global Tuberculosis Institute

Jeffery Tornheim, MD, MPH
Assistant Professor of Medicine
Johns Hopkins University

Shu-Hua Wang, PharmD, MD
Medical Director
Benjamin Franklin TB Program

Mark Wolman, MPH
Program Manager, TB Control
Global Tuberculosis Institute

Patricia Woods, RN, MSN
Public Health Nurse Consultant
TB Program, New Jersey Department of Health

Edward Zuroweste, MD
TB Medical Consultant
Pennsylvania Department of Health



 

PLANNING COMMITTEE

Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Global Tuberculosis Institute

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute


Shwata Suresh Kumar, MPH
Health Educator
Global Tuberculosis Institute

Patricia Woods, RN, MSN
Public Health Nurse Consultant
TB Program, New Jersey Department of Health